title: Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.
abstract: To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin action in skeletal muscle and fat tissue, we studied 61 men with (n = 31) or without (n = 30) diabetes, subgrouped into abdominally obese or nonobese according to the waist circumference. Adipose tissue depots were quantified by magnetic resonance imaging, and regional glucose uptake was measured using 2-[(18)F]fluoro-2-deoxyglucose/positron emission tomography during euglycemic hyperinsulinemia. Across groups, glucose uptake per unit tissue weight was higher in visceral (20.5 +/- 1.4 micromol . min(-1) . kg(-1)) than in abdominal (9.8 +/- 0.9 micromol min(-1) . kg(-1), P < 0.001) or femoral (12.3 +/- 0.6 micromol . min(-1) . kg(-1), P < 0.001) subcutaneous tissue and approximately 40% lower than in skeletal muscle (33.1 +/- 2.5 micromol . min(-1) . kg(-1), P < 0.0001). Abdominal obesity was associated with a marked reduction in glucose uptake per unit tissue weight in all fat depots and in skeletal muscle (P < 0.001 for all regions). Recent type 2 diabetes per se had little additional effect. In both intra-abdominal adipose (r = -0.73, P < 0.0001) and skeletal muscle (r = -0.53, P < 0.0001) tissue, glucose uptake was reciprocally related to intra-abdominal fat mass in a curvilinear fashion. When regional glucose uptake was multiplied by tissue mass, total glucose uptake per fat depot was similar irrespective of abdominal obesity or type 2 diabetes, and its contribution to whole-body glucose uptake increased by approximately 40% in obese nondiabetic and nonobese diabetic men and was doubled in obese diabetic subjects. We conclude that 1) in abdominal obesity, insulin-stimulated glucose uptake rate is markedly reduced in skeletal muscle and in all fat depots; 2) in target tissues, this reduction is reciprocally (and nonlinearly) related to the amount of intra-abdominal fat; 3) mild, recent diabetes adds little insulin resistance to that caused by abdominal obesity; and 4) despite fat insulin resistance, an expanded fat mass (especially subcutaneous) provides a sink for glucose, resulting in a compensatory attenuation of insulin resistance at the whole-body level in men.
authors.affiliation: Turku PET Centre, University of Turku, P.O. Box 52 20521, Turku, Finland. kirsi.virtanen@utu.fi
authors.forename: Kirsi A
authors.initials: KA
authors.lastname: Virtanen
authors.forename: Patricia
authors.initials: P
authors.lastname: Iozzo
authors.forename: Kirsti
authors.initials: K
authors.lastname: Hällsten
authors.forename: Risto
authors.initials: R
authors.lastname: Huupponen
authors.forename: Riitta
authors.initials: R
authors.lastname: Parkkola
authors.forename: Tuula
authors.initials: T
authors.lastname: Janatuinen
authors.forename: Fredrik
authors.initials: F
authors.lastname: Lönnqvist
authors.forename: Tapio
authors.initials: T
authors.lastname: Viljanen
authors.forename: Tapani
authors.initials: T
authors.lastname: Rönnemaa
authors.forename: Peter
authors.initials: P
authors.lastname: Lönnroth
authors.forename: Juhani
authors.initials: J
authors.lastname: Knuuti
authors.forename: Ele
authors.initials: E
authors.lastname: Ferrannini
authors.forename: Pirjo
authors.initials: P
authors.lastname: Nuutila
mesh_terms: D000273:Adipose Tissue / Q000502:physiology*; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism; D009765:Obesity / Q000503:physiopathology*; D049268:Positron-Emission Tomography
chemical_list: D005947:Glucose